Trump admin brings international drug pricing to Medicaid 

Presented by the Coalition to Strengthen America’s Healthcare — State Medicaid programs that choose to participate in the model will be able to purchase drugs included in the pilot at prices aligned with those paid in select other countries. {beacon} Health Care The Big Story  Trump admin brings international drug pricing to Medicaid  A new payment model from the Centers for […]

Trump announces deal to lower cost of weight loss drug

President Trump appeared in the oval office with executives from the companies behind GLP1 weight loss drug Wegovy and Zepbound to announce new costs for Medicare recipients and price reductions set to come in 2026. NBC News’ Liz Kreutz reports. For more context and news coverage of the most important stories of our day, click […]

Voters Who Oppose Wars of Choice Have Nowhere to Turn

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. Barack Obama and Donald Trump have this in common: Both owe their political ascents in part to blunt attacks […]

STAT+: Seven burning questions about Trump’s big deal for cheaper weight loss drugs

WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs has left industry leaders, public health experts, and patients with a host of open questions. The administration’s agreements with Eli Lilly and Novo Nordisk center on their much-hyped GLP-1 offerings, which officials said would now be available […]

Trump strikes deal to lower GLP-1 drug prices

US President Donald Trump on Thursday announced deals to lower the cost of weight loss drugs Wegovy and Zepbound, a move that could vastly expand access to the blockbuster medications. The agreements with pharma giants Eli Lilly and Novo Nordisk could bring the price of the GLP-1 injectables from roughly $1,350 to $149 per month. […]

STAT+: Kennedy, a longtime pharma critic, embraces Trump deal to expand access to obesity drugs

WASHINGTON — Health secretary Robert F. Kennedy Jr. was uncharacteristically chummy with pharma executives at the White House on Thursday as he cheered the Trump administration’s plan for lowering obesity medication prices. Kennedy has railed against drugmakers in the past, and his lifestyle-focused Make America Healthy Again movement has opposed Medicare coverage of GLP-1 weight loss […]

Trump Announces $250 Weight Loss Drugs In Latest ‘TrumpRx’ Deal

by Emily Kopp at CDN – President Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and Novo Nordisk in a Thursday Oval Office announcement. The obesity drugs Zepbound, marketed by Lilly, and Wegovy, marketed by Novo Nordisk, will be available at slashed prices through Trump’s innovative […]